MIM
ADMA icon

Macroview Investment Management’s ADMA Biologics ADMA Stock Holding History

Macroview Investment Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-692
Closed -$7.74K – 587
2024
Q2 		$7.74K Sell
692
-571
-45% -$4.79K 0.01% 290
2024
Q1 		$8.34K Buy
+1,263
New +$6.9K 0.01% 282

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Macroview Investment Management's ADMA Position: Q3 2024 in Review

Macroview Investment Management sold out of ADMA Biologics (ADMA) in Q3 2024, closing a stake of 692 shares — an estimated $7.74K sold.

Macroview Investment Management first reported a position in ADMA in Q1 2024 and held it in 2 quarters. The position peaked at $8.34K in Q1 2024. 306 funds tracked by Wall St. Rank hold ADMA as of Q3 2024.

  • Macroview Investment Management reported no remaining ADMA Biologics position as of Q3 2024 after selling out during the quarter.
  • Macroview Investment Management sold 692 ADMA Biologics shares in Q3 2024, an estimated $7.74K.
  • Macroview Investment Management first reported a position in ADMA Biologics in Q1 2024 and held it in 2 quarters.
  • Macroview Investment Management's ADMA Biologics position peaked at $8.34K in Q1 2024.
  • 306 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2024.

Based on Macroview Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.